Helen Ulrika Sjögren

Title: Helen Ulrika Sjögren: Innovator in Gonadotropin Formulations

Introduction

Helen Ulrika Sjögren is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceutical formulations, particularly in the stabilization of gonadotropin formulations. With a total of 5 patents to her name, her work has had a notable impact on medical science.

Latest Patents

One of her latest patents is focused on a stable liquid gonadotropin formulation. This invention pertains to the stabilization of gonadotropin formulations, specifically liquid formulations. The stabilization is achieved through a unique combination of excipients, with a preference for arginine and methionine. In a preferred embodiment, the formulation does not include a buffer, which enhances its stability and efficacy.

Career Highlights

Helen is currently associated with Ferring B.V., a company known for its innovative pharmaceutical products. Her work at Ferring has allowed her to explore and develop advanced formulations that contribute to better therapeutic outcomes.

Collaborations

Throughout her career, Helen has collaborated with notable colleagues, including Heidi Louise Bagger and Charlotte Hojer-Pedersen. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Helen Ulrika Sjögren's contributions to the field of gonadotropin formulations exemplify her dedication to advancing medical science. Her innovative work continues to influence the development of effective pharmaceutical solutions.